CNMD's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 214.84 -- higher than 84.57% of US-listed equities with positive expected earnings growth.
Conmed Corp's stock had its IPO on March 26, 1990, making it an older stock than 83.88% of US equities in our set.
With a price/earnings ratio of 63.5, Conmed Corp P/E ratio is greater than that of about 89.78% of stocks in our set with positive earnings.
Stocks that are quantitatively similar to CNMD, based on their financial statements, market capitalization, and price volatility, are GCP, LNN, CMD, EML, and NVT.
CNMD's SEC filings can be seen here. And to visit Conmed Corp's official web site, go to www.conmed.com.
CONMED Corporation is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. The company was founded in 1970 and is based in Utica, New York.
CNMD Price Forecast Based on DCF Valuation
DCF Fair Value Target:
We started the process of determining a valid price forecast for Conmed Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Conmed Corp ranked in the 26th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for CNMD, they are:
Conmed Corp's weighted average cost of capital (WACC) is 8%; for context, that number is higher than 61.81% of tickers in our DCF set.
CNMD's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 7%; for context, that number is higher than 61.81% of tickers in our DCF set.
Relative to other stocks in its sector (Healthcare), Conmed Corp has a reliance on debt greater than 72.84% of them.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as CNMD, try ABT, NUVA, ENTA, TMO, and BHC.
CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on July 6, 2020 to all shareholders of record as of June 15, 2020.
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that its 2020 Annual Meeting of Shareholders, scheduled for May 21, 2020, at 1:30 p.m. ET, will be hosted as a virtual-only meeting due to public health concerns and social-distancing restrictions imposed by governmental authorities with respect to non-essential gatherings arising from the COVID-19 pandemic. Information about the virtual meeting webcast and instructions for how shareholders can participate in the Annu
DUBLIN--(BUSINESS WIRE)--The "Global Electrosurgery Devices Market By Product (Electrosurgical Generators, Electrosurgical Instruments, Accessories), By Application, By End-user, By Region, Forecast & Opportunities, 2025" report has been added to ResearchAndMarkets.com's offering. The Global Electrosurgery Devices Market is expected to grow at a steady rate during the forecast period. Growing trend of plastic surgeries, initiated by the celebrities to look younger has influenced a large par